… or to any other excipients.
- Patients in whom asthma, bronchospasm, angioedema, urticaria, or acute rhinitis are precipitated by aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs).
- Peptic ulceration and those with a history of peptic ulceration;
- History of upper gastrointestinal bleeding or perforation, related to previous NSAID therapy.
- History of hemophilia, hypothrombinemia or other clotting disorders
- Renal failure (GFR < 15mL/ …
Identical in both labels. Surrounding text shown from Haleon UK Trading Limited.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Hypoprothrombinaemia, haemophilia, haemorrhagic disease or a history of bleeding disorders, cerebral haemorrhage and active peptic ulceration or a history of peptic ulceration.
Third trimester of pregnancy (see section 4.6).
In women who are breastfeeding (see section 4.6).
… similar mechanism of action, especially non-steroidal anti-inflammatory drugs (NSAIDs) A history of asthma caused by salicylates or substances with a similar mechanism of action, especially NSAIDs; - Acute gastrointestinal ulcers; - A history of gastrointestinal bleeding or perforation (gastric or intestinal failure) caused by previous NSAID therapy; - Active or a history of recurrent gastric and duodenal ulcer/haemorrhage wit …
… tors (e.g. certain asthma patients who may suffer an attack or faint and certain patients who may suffer from bronchospasm, rhinitis and urticaria), or to any of the excipients (see section 6.1).
• Active, or history of recurrent peptic ulcer and/or gastric/intestinal haemorrhage, or other kinds of bleeding such as cerebrovascular haemorrhages.
• Haemorrhagic diathesis; coagulation disorders such as haemophilia and thrombocytopenia.
• Patients who are suffering from gout.
• Severe hepatic impairment.
• Severe renal impairment.
• …
… may have developed anaphylaxis, angioedema, asthma, rhinitis or urticaria induced by aspirin or other NSAIDs).
• Nasal polyps associated with asthma (high risk of severe sensitivity reactions).
• Active peptic ulceration or a past history of ulceration or dyspepsia.
• Haemophilia or other haemorrhagic disorder (including thrombocytopenia) as there is an increased risk of bleeding.
• Concurrent anticoagulant therapy should be avoided.
• Severe hepatic impai …
Hypersensitivity to acetylsalicylic acid or to any of the excipients listed in section 6.1.
Hypersensitivity to other non-steroidal anti-inflammatory drugs.
Nasal polyps associated with asthma.
Should not be given to patients suffering from a previous history of peptic ulceration or active peptic ulceration or bleeding disorders including haemophilia.
Disprin contains soy protein. If you are allergic to peanut or soya do not use this medicinal product.
Severe hepatic impairment.
Severe renal impairment.
Severe heart failure.
Children aged und …